Skip to main content
C

Cathay Chemical Works Inc. — Investor Relations & Filings

Ticker · 1713 TW Manufacturing
Open in API
Filings indexed 1,299 across all filing types
Latest filing 2026-05-04 Regulatory Filings
Country TW Taiwan
Listing TW 1713

About Cathay Chemical Works Inc.

https://www.ccwi.com.tw

Cathay Chemical Works Inc. is an established manufacturer specializing in the production and distribution of high-quality chemical products. With over five decades of expertise, the company maintains a leading market position in the manufacturing of Sodium Formaldehyde Sulfoxylate, Sodium Metabisulfite, Zinc Oxide, and Zinc Powder. Its core product portfolio also includes Sodium Hydrosulfite and Calcined Zinc. Cathay Chemical Works Inc. focuses on advanced manufacturing technologies to ensure high production efficiency, cost-competitiveness, and consistent quality standards. Beyond manufacturing, the company engages in the wholesale and retail of chemical raw materials and provides international trade and agency services. Its products serve diverse industrial sectors, supported by a long-standing reputation for reliability and technical excellence in the chemical processing field.

Recent filings

Filing Released Lang Actions
115年04月內部人持股異動(事後)
Regulatory Filings
2026-05-04 Chinese
115年04月董事會成員及持股
Regulatory Filings
2026-05-04 Chinese
115年第一季財務報告董事會預計召開日期為115年05月07日
Report Publication Announcement Classification · 1% confidence The document is a public filing from the Taiwanese Market Observation Post System announcing the board meeting schedule to review and approve the Q1 (first quarter) financial report. It does not contain the actual financial figures or detailed results, nor is it a management change or dividend notice. Rather, it simply notifies the timing for the report’s approval. Under our taxonomy, such notices about report timing/publication fall under Report Publication Announcement (RPA).
2026-04-28 Chinese
114年第4季財務報告書 — 202504_1713_AIB.pdf
Regulatory Filings
2026-04-21 Chinese
115年3月背書保證與資金貸與
Regulatory Filings Classification · 1% confidence The document is a standard regulatory disclosure from Taiwan’s Market Observation Post System (“公開資訊觀測站”) showing monthly data on fund loans and endorsement/guarantee balances. It is not an earnings release, management discussion, annual/interim report, or investor presentation. It is a routine compliance filing without attachment of a full report, fitting the “Regulatory Filings” fallback category.
2026-04-02 Chinese
115年3月營業收入
Regulatory Filings Classification · 1% confidence The document is a short (764-character) monthly operating revenue summary table provided via Taiwan’s MOPS system, listing IFRS net sales for a single month and year-to-date. It is not a full annual or interim report, not an earnings release (which would summarize quarterly results), nor a dividend/financing/capital notice. It is a routine regulatory submission of periodic financial data. Because no specific category covers monthly revenue filings, the fallback “Regulatory Filings” (RNS) is most appropriate.
2026-04-02 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.